Search clinical trials for: Acuvue Oasys

Total 2300 results

Boston Therapeutics

Completed

Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™

Postprandial Hyperglycemia
Genzyme, a Sanofi Company

Completed

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

United States, Czech Republic, Hungary
National Guard Health Affairs

Suspended

Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer (TAXIS01)

Non-small Cell Lung Cancer Metastatic

Saudi Arabia
Samsung Medical Center

Unknown

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Nasopharyngeal Cancer

Korea, Republic of
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.; Aventis Pharmaceuticals

Completed

Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer

Prostate Cancer
Universidade do Porto

Withdrawn

Inter- and Intra-individual Variation in Acute Responses to Two Different Warm-up Types.

Healthy

Portugal
Acerta Pharma BV
Acerta Pharma, LLC

Completed

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Multiple Myeloma (MM)

United States, United Kingdom
Samsung Medical Center

Completed

Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With MET Overexpression as a Second-line Treatment

Advanced Gastric Adenocarcinoma

Korea, Republic of
Sichuan Cancer Hospital and Research Institute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC

Lung Cancer | Lung Cancer Metastatic

China
Newcastle University

Completed

The Effect of Date Fruit on Mood and Cognition in Healthy Adults

Mood and Cognitive Performance

United Kingdom
Masonic Cancer Center, University of Minnesota

Completed

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Docetaxel in Treating Patients With Relapsed Prostate Cancer

Prostate Cancer

United States
Biogen
Elan Pharmaceuticals

Completed

Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

Crohn's Disease

United States
University Hospital, Rouen

Completed

Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs (VIRIDAE)

Epilepsy | Drug Hypersensitivity Syndrome

France
University Hospital, Caen

Completed

Effects of Neuro-myo-electrical Stimulation on Insulin Sensitivity in Patients With Type 2 Diabetes (ELECTRODIAB)

Type 2 Diabetes

France
Astellas Pharma Inc

Completed

A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

Melanoma

United States, Canada
Pfizer

Completed

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Advanced Non-Hematologic Malignancies

United Kingdom
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Children With Recurrent Solid Tumors

Sarcoma | Brain and Central Nervous System Tumors | Neuroblastoma

United States, Australia, Canada
Hanjong Ahn

Unknown

Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer

Prostate Cancer

Korea, Republic of
Xuekui Liu

Recruiting

Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma (NCCCNRHNSCC)

Head and Neck Squamous Cell Carcinoma | Locally Advanced Operable

China
Assiut University

Not yet recruiting

Emergency Versus Elective Cholecystectomy in Acute Cholecystitis in the Era of Laparoscopy.

Cholecystitis, Acute
University of Florida

Recruiting

Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery

Orthopedic Disorder | Arthropathy of Knee | Arthropathy of Hip | Lower Extremity Fracture

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Assistance Publique Hopitaux De Marseille

Completed

Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy (5-FU)

Patients With Head and Neck Cancer (ORL)

France
Spanish Breast Cancer Research Group
Novartis

Completed

Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients (EDALINE)

Advanced Breast Cancer

Spain
Cellxpert Biotechnology Corp.
Medigen Biotechnology Corporation

Completed

Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Australia
Novartis Pharmaceuticals

Completed

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Classical Hodgkin's Lymphoma

Spain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Prostate Cancer Metastatic

China
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Solid Tumors

United States
Ryo Itabashi

Completed

Carotid Duplex Ultrasound for Selecting Patients for Endovascular Thrombectomy in Acute Stroke Patients (ECHO-SELECT)

Stroke, Acute

Japan
Samsung Medical Center

Completed

Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy

Gastric Adenocarcinoma

Korea, Republic of
Penumbra Inc.

Completed

A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial (FIRST)

Stroke

China, United States
Montefiore Medical Center
National Cancer Institute (NCI)

Completed

Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Yale University
National Cancer Institute (NCI)

Terminated

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Leonard Appleman
Sanofi-Synthelabo

Completed

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Metastatic Transitional Cell Cancer of the Urothelial Tract

United States
Asan Medical Center
Novartis Pharmaceuticals

Completed

Dovitinib Plus Docetaxel in Gastric Cancer

Gastric Cancer

Korea, Republic of
Asan Medical Center
Boryung Pharmaceutical Co., Ltd

Unknown

Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer

Endometrial Cancer

Korea, Republic of
Pfizer

Withdrawn

A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

Breast Neoplasms
Swiss Group for Clinical Cancer Research

Completed

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Esophageal Cancer

Switzerland
Benaroya Research Institute
Sanofi; Cell Genesys

Terminated

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Prostate Cancer

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Non-Small Cell Lung Cancer

Greece
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel

Advanced Solid Tumors

China
Shirley Ryan AbilityLab

Recruiting

A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury (HANDS)

Spinal Cord Injuries

United States
Novartis Pharmaceuticals

Terminated

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy (CANOPY-2)

Non-Small-Cell Lung

Germany, Spain, Belgium, Canada, Netherlands, Italy, Taiwan, Argentina, Australia, Israel, Japan, Lebanon, France, Poland, United States, Jordan, Korea, Republic of, China, Brazil, Czechia, Greece, Russian Federation, Denmark, Hungary, ... and more
Yong Fang
Zhejiang Cancer Hospital; Zhejiang Provincial People's Hospital; Ningbo No. 1... and other collaborators

Unknown

Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC (ACWDVDFPTAN)

Non-small Cell Lung Cancer

China
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; The People's... and other collaborators

Unknown

A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC (ALTER-L024)

Non-small Cell Lung Cancer

China
Cascadian Therapeutics Inc.

Completed

Study of PX-866 and Docetaxel in Solid Tumors

Non Small Cell Lung Cancer (NSCLC) | Squamous Cell Carcinoma of the Head and Neck (SCCHN)

United States, Canada
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Squamous Cell Carcinoma

China
Achieve Life Sciences

Completed

Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer

Neoplasms

United States, Canada
Shandong Cancer Hospital and Institute

Unknown

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Non Small Cell Lung Cancer

China

Search clinical trials for: Acuvue Oasys

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations